Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
Condition: Glioblastoma · Malignant Glioma · Recurrent Glioblastoma · Sponsor: Sabine Mueller, MD, PhD
About this study
This phase I trial studies the side effects of nivolumab before and after surgery in treating children and young adults with high grade glioma that has come back (recurrent) or is increasing in scope or severity (progressive). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (20)
| University of Alabama at Birmingham, Children's of Alabama | Birmingham, Alabama, United States | — |
| Children's Hospital of Los Angeles | Los Angeles, California, United States | — |
| Rady Children's Hospital | San Diego, California, United States | — |
| University of California, San Francisco | San Francisco, California, United States | — |
| Children's National Hospital | Washington D.C., District of Columbia, United States | — |
| University of Florida | Gainesville, Florida, United States | — |
| Riley Children's Hospital | Indianapolis, Indiana, United States | — |
| Johns Hopkins University | Baltimore, Maryland, United States | — |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | — |
| Washington University St. Louis | St Louis, Missouri, United States | — |
| Hackensack Meridian Children's Health at Joseph M. Sanzari Children's Hospital | Hackensack, New Jersey, United States | — |
| Duke Children's Hospital & Health Center | Durham, North Carolina, United States | — |
+ 8 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04323046